These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 29062027)

  • 1. Harnessing a catalytic lysine residue for the one-step preparation of homogeneous antibody-drug conjugates.
    Nanna AR; Li X; Walseng E; Pedzisa L; Goydel RS; Hymel D; Burke TR; Roush WR; Rader C
    Nat Commun; 2017 Oct; 8(1):1112. PubMed ID: 29062027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Engineering Dual Variable Domains for the Generation of Site-Specific Antibody-Drug Conjugates.
    Nanna AR; Rader C
    Methods Mol Biol; 2019; 2033():39-52. PubMed ID: 31332746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Site-Selective Antibody Functionalization via Orthogonally Reactive Arginine and Lysine Residues.
    Hwang D; Nilchan N; Nanna AR; Li X; Cameron MD; Roush WR; Park H; Rader C
    Cell Chem Biol; 2019 Sep; 26(9):1229-1239.e9. PubMed ID: 31231031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficient Preparation of Site-Specific Antibody-Drug Conjugates Using Cysteine Insertion.
    Dimasi N; Fleming R; Zhong H; Bezabeh B; Kinneer K; Christie RJ; Fazenbaker C; Wu H; Gao C
    Mol Pharm; 2017 May; 14(5):1501-1516. PubMed ID: 28245132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design and characterization of homogenous antibody-drug conjugates with a drug-to-antibody ratio of one prepared using an engineered antibody and a dual-maleimide pyrrolobenzodiazepine dimer.
    White JB; Fleming R; Masterson L; Ruddle BT; Zhong H; Fazenbaker C; Strout P; Rosenthal K; Reed M; Muniz-Medina V; Howard P; Dixit R; Wu H; Hinrichs MJ; Gao C; Dimasi N
    MAbs; 2019 Apr; 11(3):500-515. PubMed ID: 30835621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proof of site-specificity of antibody-drug conjugates produced by chemical conjugation technology: AJICAP first generation.
    Matsuda Y; Malinao MC; Robles V; Song J; Yamada K; Mendelsohn BA
    J Chromatogr B Analyt Technol Biomed Life Sci; 2020 Mar; 1140():121981. PubMed ID: 32036254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sortase Enzyme-Mediated Generation of Site-Specifically Conjugated Antibody Drug Conjugates with High In Vitro and In Vivo Potency.
    Beerli RR; Hell T; Merkel AS; Grawunder U
    PLoS One; 2015; 10(7):e0131177. PubMed ID: 26132162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conjugation site analysis of antibody-drug-conjugates (ADCs) by signature ion fingerprinting and normalized area quantitation approach using nano-liquid chromatography coupled to high resolution mass spectrometry.
    Sang H; Lu G; Liu Y; Hu Q; Xing W; Cui D; Zhou F; Zhang J; Hao H; Wang G; Ye H
    Anal Chim Acta; 2017 Feb; 955():67-78. PubMed ID: 28088282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current ADC Linker Chemistry.
    Jain N; Smith SW; Ghone S; Tomczuk B
    Pharm Res; 2015 Nov; 32(11):3526-40. PubMed ID: 25759187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficient Preparation of Site-Specific Antibody-Drug Conjugates Using Phosphopantetheinyl Transferases.
    Grünewald J; Klock HE; Cellitti SE; Bursulaya B; McMullan D; Jones DH; Chiu HP; Wang X; Patterson P; Zhou H; Vance J; Nigoghossian E; Tong H; Daniel D; Mallet W; Ou W; Uno T; Brock A; Lesley SA; Geierstanger BH
    Bioconjug Chem; 2015 Dec; 26(12):2554-62. PubMed ID: 26588668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conjugation Site Analysis of Lysine-Conjugated ADCs.
    Sang H; Wan N; Lu G; Tian Y; Wang G; Ye H
    Methods Mol Biol; 2020; 2078():235-250. PubMed ID: 31643061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Novel Platinum(II)-Based Bifunctional ADC Linker Benchmarked Using 89Zr-Desferal and Auristatin F-Conjugated Trastuzumab.
    Sijbrandi NJ; Merkul E; Muns JA; Waalboer DC; Adamzek K; Bolijn M; Montserrat V; Somsen GW; Haselberg R; Steverink PJ; Houthoff HJ; van Dongen GA
    Cancer Res; 2017 Jan; 77(2):257-267. PubMed ID: 27872093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Site-Specific Dual Antibody Conjugation via Engineered Cysteine and Selenocysteine Residues.
    Li X; Patterson JT; Sarkar M; Pedzisa L; Kodadek T; Roush WR; Rader C
    Bioconjug Chem; 2015 Nov; 26(11):2243-8. PubMed ID: 26161903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Site-Specific Antibody-Drug Conjugates in Triple Variable Domain Fab Format.
    Hwang D; Rader C
    Biomolecules; 2020 May; 10(5):. PubMed ID: 32422893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Novel Anti-CD22 Anthracycline-Based Antibody-Drug Conjugate (ADC) That Overcomes Resistance to Auristatin-Based ADCs.
    Yu SF; Zheng B; Go M; Lau J; Spencer S; Raab H; Soriano R; Jhunjhunwala S; Cohen R; Caruso M; Polakis P; Flygare J; Polson AG
    Clin Cancer Res; 2015 Jul; 21(14):3298-306. PubMed ID: 25840969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug-to-antibody determination for an antibody-drug-conjugate utilizing cathepsin B digestion coupled with reversed-phase high-pressure liquid chromatography analysis.
    Adamo M; Sun G; Qiu D; Valente J; Lan W; Song H; Bolgar M; Katiyar A; Krishnamurthy G
    J Chromatogr A; 2017 Jan; 1481():44-52. PubMed ID: 28017567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biophysical Properties and Heating-Induced Aggregation of Lysine-Conjugated Antibody-Drug Conjugates.
    Gandhi AV; Arlotta KJ; Chen HN; Owen SC; Carpenter JF
    J Pharm Sci; 2018 Jul; 107(7):1858-1869. PubMed ID: 29626535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Site-Specific Conjugation of the Indolinobenzodiazepine DGN549 to Antibodies Affords Antibody-Drug Conjugates with an Improved Therapeutic Index as Compared with Lysine Conjugation.
    Bai C; Reid EE; Wilhelm A; Shizuka M; Maloney EK; Laleau R; Harvey L; Archer KE; Vitharana D; Adams S; Kovtun Y; Miller ML; Chari R; Keating TA; Yoder NC
    Bioconjug Chem; 2020 Jan; 31(1):93-103. PubMed ID: 31747250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Site-specific antibody-drug conjugation through an engineered glycotransferase and a chemically reactive sugar.
    Zhu Z; Ramakrishnan B; Li J; Wang Y; Feng Y; Prabakaran P; Colantonio S; Dyba MA; Qasba PK; Dimitrov DS
    MAbs; 2014; 6(5):1190-200. PubMed ID: 25517304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stable and Potent Selenomab-Drug Conjugates.
    Li X; Nelson CG; Nair RR; Hazlehurst L; Moroni T; Martinez-Acedo P; Nanna AR; Hymel D; Burke TR; Rader C
    Cell Chem Biol; 2017 Apr; 24(4):433-442.e6. PubMed ID: 28330604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.